Reagents and consumables

Ended Awarded

Contract number
75N91021F00218
Awardee
Awarding agency
Obligated
$13,815

Award facts

Contract value 100% obligated
$13,815.26 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

Roche Diagnostics Corporation has been awarded a $13,815.26 firm fixed price delivery order for reagents and consumables in support of Ventana Medical Systems Benchmark Ultra immunostainers. The contract has no set-aside designation and was awarded by the National Cancer Institute within the National Institutes of Health of the Department of Health and Human Services. The reagents and consumables will be provided for use in immunohistochemistry and in situ hybridization tests conducted on the Benchmark Ultra platforms. Delivery will occur to the stated place of performance in Castleton, Indiana. No subcontractors were identified.

Quick answers

Who was awarded contract 75N91021F00218?

75N91021F00218 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on August 2, 2021.

How much is contract 75N91021F00218 worth?

The government has obligated $13,815 on 75N91021F00218.

Is contract 75N91021F00218 an order under another contract?

Yes. 75N91021F00218 is a delivery order under 75N91019D00038, an indefinite delivery contract.

Was contract 75N91021F00218 competed?

The extent of competition for 75N91021F00218 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award